​

GlycoMimetics (GLYC) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

GLYC Stock Rating

GlycoMimetics stock's rating consensus is Buy, based on 13 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 8 Buy (61.54%), 5 Hold (38.46%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 13 0 5 8 Strong Sell Sell Hold Buy Strong Buy

GLYC Price Target Upside V Benchmarks

TypeNameUpside
StockGlycoMimetics-
SectorHealthcare Stocks 23.68%
IndustryBiotech Stocks 64.77%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$0.17$0.17$0.17
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 25-2---2
May, 25-2---2
Apr, 25-2---2
Mar, 25-1---1
Feb, 25-1---1
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jul 26, 2024Cowen & Co.Holddowngrade
May 06, 2024H.C. WainwrightNeutraldowngrade

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.10$-1.23$-1.78$-0.58$-0.59----
Avg Forecast$-1.08$-1.25$-0.87$-0.60$-0.51$-0.09$-0.07$-1.85$-2.00
High Forecast$-1.08$-1.25$-0.87$-0.59$-0.51$-0.09$-0.07$-1.85$-2.00
Low Forecast$-1.08$-1.25$-0.87$-0.64$-0.51$-0.09$-0.07$-1.85$-2.00
Surprise %1.85%-1.60%104.60%-3.33%15.69%----

Revenue Forecast

$0 $3M $6M $9M $12M $15M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$10.16M$1.16M$74.92K$10.00K-----
Avg Forecast$10.00M$835.50K$66.67K$10.00K$10.00K$2.67M$1.27M$5.54M$15.00M
High Forecast$10.00M$835.50K$66.67K$10.00K$10.00K$2.67M$1.27M$5.54M$15.00M
Low Forecast$10.00M$835.50K$66.67K$10.00K$10.00K$2.67M$1.27M$5.54M$15.00M
Surprise %1.63%38.84%12.39%------

Net Income Forecast

$-150M $-120M $-90M $-60M $-30M $0 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-50.27M$-63.14M$-93.33M$-36.90M-----
Avg Forecast$-68.54M$-79.02M$-55.11M$-39.12M$-32.30M$-5.70M$-4.43M$-117.18M$-126.68M
High Forecast$-68.54M$-79.02M$-55.11M$-37.53M$-32.30M$-5.70M$-4.43M$-117.18M$-126.68M
Low Forecast$-68.54M$-79.02M$-55.11M$-40.71M$-32.30M$-5.70M$-4.43M$-117.18M$-126.68M
Surprise %-26.65%-20.09%69.36%-5.67%-----

GLYC Forecast FAQ

Is GlycoMimetics stock a buy?

GlycoMimetics stock has a consensus rating of Buy, based on 13 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 8 Buy, 5 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that GlycoMimetics is a favorable investment for most analysts.

What is GlycoMimetics's price target?

GlycoMimetics's price target, set by 13 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $0.17.

How does GlycoMimetics stock forecast compare to its benchmarks?

GlycoMimetics's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (23.68%) and underperforming the biotech stocks industry (64.77%).

What is the breakdown of analyst ratings for GlycoMimetics over the past three months?

  • June 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is GlycoMimetics’s EPS forecast?

GlycoMimetics's average annual EPS forecast for its fiscal year ending in December 2025 is $-0.09, marking a -84.75% decrease from the reported $-0.59 in 2024. Estimates for the following years are $-0.07 in 2026, $-1.85 in 2027, and $-2 in 2028.

What is GlycoMimetics’s revenue forecast?

GlycoMimetics's average annual revenue forecast for its fiscal year ending in December 2025 is $2.67M, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $1.27M, followed by $5.54M for 2027, and $15M for 2028.

What is GlycoMimetics’s net income forecast?

GlycoMimetics's net income forecast for the fiscal year ending in December 2025 stands at $-5.701M, representing a 0% decrease from the reported $0 in 2024. Projections indicate $-4.434M in 2026, $-117M in 2027, and $-127M in 2028.